ITRM vs MET · rev $390.0K vs P/E 13, $52.16B cap
Iterum Therapeutics PLC (ITRM) versus MetLife Inc (MET) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
MetLife Inc (MET) is a insurance - life company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
MET does not have a complete income-statement cache yet.
ITRM currently screens at market cap $38.6M. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Not investment advice. Open the ITRM and MET stock pages for the full models.
Not investment advice.